Boothbay Fund Management, LLC Collegium Pharmaceutical, Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $214,508 - $314,974	-15,085 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $259,462 - $339,412	15,085 New	15,085 $307,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $560,778 - $876,018	-52,804 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $717,078 - $988,490	52,804 New	52,804 $799,000
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $343,192 - $445,567	-15,750 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$18.15 - $29.21 $285,862 - $460,057	15,750 New	15,750 $402,000

236

39.4M

84.2K

18.6K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.